CORE Scientific CFO sells stock worth $12,544 through Investing.com

Sterling Denise Marie Brucia, CFO of Core Scientific, Inc. (NASDAQ:), recently sold a portion of its holdings in the company. The transaction comes as Core Scientific is showing great performance in the market, with the stock up 375% over the past year and currently trading at $16.34. according to InvestingPro Analysis, the stock appears to be overvalued relative to its fair value, although analysts maintain a positive outlook with price targets ranging from $17 to $26. According to a filing with the Securities and Exchange Commission, Proscia sold 802 shares of common stock on January 22, 2025, at an average price of $15,641 per share, for a total transaction value of $12,544. This sale was made to satisfy the tax liability on the restricted stock units, as described in the filing. Following the transaction, Brucia owns 440,028 shares of Core Scientific. InvestingPro Subscribers can access 14 additional investment tips and a comprehensive pro report to gain deeper insights into Core Scientific’s financial health, which is currently rated as Good.

In other recent news, Core Scientific Inc . Big moves have been made in the AI ​​and high-performance computing (HPC) space. The company has begun construction on a new 100-megawatt data center in Muskogee, Oklahoma, as part of a larger agreement with Coreave. This new facility will support Nvidia’s (NASDAQ:) GPUs for a confidential client, contributing to a total of 500 megawatts of contracted IT load for its HPC hosting operations.

Craig-Hallum initiated coverage on Basic Scientific shares with a Buy rating and $24.00 price target. The analyst praised the recent CoreWeave deal from Core Scientific and noted the company’s potential for growth. Compass Point also raised its price target on Core Scientific from $20.00 to $26.00, while maintaining a “buy” rating on the stock.

The company also announced plans to offer $500 million of convertible senior notes, with the aim of attracting qualified institutional investors. This financial maneuver is part of the company’s efforts to secure additional financing.

These recent developments highlight Core Scientific’s ongoing efforts to expand its high-performance computing capabilities, secure additional financing, and diversify its customer base.

This article was created with the power of artificial intelligence and reviewed by an editor. For more information, see T&C.